東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

A Comparison of Co-Stimulatory HVEM Domains in Second Generation CAR-T Cells.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	A Comparison of Co-Stimulatory HVEM Domains in Second Generation CAR-T Cells./
作者:	Hennecke, Derek.
面頁冊數:	1 online resource (109 pages)
附註:	Source: Masters Abstracts International, Volume: 84-05.
Contained By:	Masters Abstracts International84-05.
標題:	Immunology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29397764click for full text (PQDT)
ISBN:	9798352913161

A Comparison of Co-Stimulatory HVEM Domains in Second Generation CAR-T Cells.
Hennecke, Derek.

A Comparison of Co-Stimulatory HVEM Domains in Second Generation CAR-T Cells. - 1 online resource (109 pages)

Source: Masters Abstracts International, Volume: 84-05.

Thesis (A.L.M.)--Harvard University, 2022.

Includes bibliographical references

Chimeric antigen receptor T cells (CAR-T) are T cells that have been genetically modified to express a receptor that recognizes a specific target molecule. When T cells bind to their target molecule, usually a surface antigen expressed on a tumor cell, they exhibit effector functions similar to T cells, including proliferation, cytokine secretion, and target cell killing. First-generation CAR-T cells contained only a synthetic receptor coupled to the CD3ζ signaling domain of the T cell receptor complex. Although first-generation CAR-T cells functioned well in vitro, they were generally unable to kill tumor cells effectively in mouse models. Second-generation CAR-T cells, which contain an intracellular co-stimulatory domain in tandem with the CD3ζ signaling domain, significantly improved the function of CAR-T cells and are now the basis for several approved therapies targeting lymphomas and leukemias. The choice of a costimulatory molecule (co-stim domain) is critical in ensuring CAR-T persistence and clinical response. As relapse rates in CAR-T recipients are still considerable, identifying new potential co-stim domains may be essential to improve clinical performance. The costimulatory domain of Herpes Virus Entry Mediator (HVEM) is a promising costimulatory domain in CAR-T cell models and might strike a "Goldilocks balance" between performance characteristics of the only co-stim domains in approved CAR-T therapies: CD-28 and 4-IBB. Mutated forms of the HVEM costimulatory domain were created to identify which components are critical to its function by generating HVEM variants with mutations in three key regions of the HVEM cytoplasmic domain (referred to as M83): deletion of a membrane-proximal α -helix, deletion of a small tail domain, and a point mutation in a potentially critical TRAF signaling domain.Upon coculture of anti-CD19 CAR-T cells containing modified M83 domains with target cell lines, altered CAR-T activation responses emerged as a function of specific co-stim domain modifications. The loss of the membrane-proximal α-helix severely ablated CAR activation. Mutating the M83 TRAF binding domain reduced the expression of the activation marker relative to wild-type M83 and CAR-T cells without a co-stim domain. Deleting the C-terminal tail domain produced a minimum impact on activation. However, interesting trends in the general responses of CAR-T culture to target cells can potentially indicate a change in the dynamics of TRAF signaling, suggesting increased non-canonical NF-κB (ncNFκB) signaling, which could encourage longer persistence of CAR-T cells. Although more work is needed to confirm these observations, this work strongly suggests that using a truncated M83 as the CAR-T co-stim domain may improve the persistence and efficacy of CAR-T cells.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798352913161Subjects--Topical Terms:

611031
Immunology.
Subjects--Index Terms:

CAR-TIndex Terms--Genre/Form:

542853
Electronic books.

A Comparison of Co-Stimulatory HVEM Domains in Second Generation CAR-T Cells.
LDR:04212nmm a2200433K 4500 001 2359850
005 20230917195304.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798352913161
035 $a (MiAaPQ)AAI29397764
035 $a AAI29397764
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Hennecke, Derek. $3 3700463
245 1 2 $a A Comparison of Co-Stimulatory HVEM Domains in Second Generation CAR-T Cells.
264 0 $c 2022
300 $a 1 online resource (109 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Masters Abstracts International, Volume: 84-05.
500 $a Advisor: Nicholson, Mike.
502 $a Thesis (A.L.M.)--Harvard University, 2022.
504 $a Includes bibliographical references
520 $a Chimeric antigen receptor T cells (CAR-T) are T cells that have been genetically modified to express a receptor that recognizes a specific target molecule. When T cells bind to their target molecule, usually a surface antigen expressed on a tumor cell, they exhibit effector functions similar to T cells, including proliferation, cytokine secretion, and target cell killing. First-generation CAR-T cells contained only a synthetic receptor coupled to the CD3ζ signaling domain of the T cell receptor complex. Although first-generation CAR-T cells functioned well in vitro, they were generally unable to kill tumor cells effectively in mouse models. Second-generation CAR-T cells, which contain an intracellular co-stimulatory domain in tandem with the CD3ζ signaling domain, significantly improved the function of CAR-T cells and are now the basis for several approved therapies targeting lymphomas and leukemias. The choice of a costimulatory molecule (co-stim domain) is critical in ensuring CAR-T persistence and clinical response. As relapse rates in CAR-T recipients are still considerable, identifying new potential co-stim domains may be essential to improve clinical performance. The costimulatory domain of Herpes Virus Entry Mediator (HVEM) is a promising costimulatory domain in CAR-T cell models and might strike a "Goldilocks balance" between performance characteristics of the only co-stim domains in approved CAR-T therapies: CD-28 and 4-IBB. Mutated forms of the HVEM costimulatory domain were created to identify which components are critical to its function by generating HVEM variants with mutations in three key regions of the HVEM cytoplasmic domain (referred to as M83): deletion of a membrane-proximal α -helix, deletion of a small tail domain, and a point mutation in a potentially critical TRAF signaling domain.Upon coculture of anti-CD19 CAR-T cells containing modified M83 domains with target cell lines, altered CAR-T activation responses emerged as a function of specific co-stim domain modifications. The loss of the membrane-proximal α-helix severely ablated CAR activation. Mutating the M83 TRAF binding domain reduced the expression of the activation marker relative to wild-type M83 and CAR-T cells without a co-stim domain. Deleting the C-terminal tail domain produced a minimum impact on activation. However, interesting trends in the general responses of CAR-T culture to target cells can potentially indicate a change in the dynamics of TRAF signaling, suggesting increased non-canonical NF-κB (ncNFκB) signaling, which could encourage longer persistence of CAR-T cells. Although more work is needed to confirm these observations, this work strongly suggests that using a truncated M83 as the CAR-T co-stim domain may improve the persistence and efficacy of CAR-T cells.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Immunology. $3 611031
650 4 $a Medicine. $3 641104
650 4 $a Pharmaceutical sciences. $3 3173021
650 4 $a Cellular biology. $3 3172791
650 4 $a Oncology. $3 751006
653 $a CAR-T
653 $a Chimeric antigen receptor-modified T
653 $a HVEM
653 $a Immunotherapy
653 $a Lymphoma
653 $a TRAF
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0982
690 $a 0564
690 $a 0572
690 $a 0379
690 $a 0992
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a Harvard University. $b Extension Studies. $3 3560717
773 0 $t Masters Abstracts International $g 84-05.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29397764 $z click for full text (PQDT)